Last reviewed · How we verify
NCT05734287
The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Cohort Study
trial testing clinical, biophysical and biochemical assessment of young females with clinical hyperandrogenism in PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries in 260 participants. Currently enrolling.
15 July 2025
Quick facts
| Lead sponsor | Woman's Health University Hospital, Egypt |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 260 |
| Start date | 28 June 2024 |
| Primary completion | 15 July 2025 |
| Estimated completion | 1 August 2025 |
| Sites | 1 location across Qatar |
Drugs / interventions tested
- clinical, biophysical and biochemical assessment of young females with clinical hyperandrogenism
Conditions studied
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries — all drugs for PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries →
Sponsor
Woman's Health University Hospital, Egypt
Who can join
Adults 15 to 35, female only, with PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This mixed cohort study will test the frequency of PCOS among young females presenting with one of the clinical hyperandrogenism criteria: acne, hirsutism and/or hair loss. Diagnosis will be based on the recent PCOS clinical, biochemical and biophysical criteria recently published " International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) 2018".
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05734287
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Currently open trials in the same condition.
- NCT07182526 — Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycys · Phase 2 · recruiting
- NCT06050265 — Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome · NA · active not recruiting
- NCT05819853 — Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome · Phase 3 · recruiting
- NCT05756023 — IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome · NA · recruiting
- NCT06041204 — Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism · NA · recruiting
Other Woman's Health University Hospital, Egypt trials
Trials by the same sponsor.
- NCT05771922 — Implication of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
- NCT05778279 — Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
- NCT04357054 — Darwish Hysteroscopic Test (Hysteroscopic Bubble Suction and Tubal Peristalsis of Darwish Triad) in Myomatous Uterus · NA · unknown
- NCT04825041 — Efficacy of Hysteroscopic Bubble Test, Flow Test and Peristalsis Test. · completed
- NCT05042895 — Hysteroscopic Findings in Ovarian Polycystic and Unexplained Infertile Women. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05734287 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Woman's Health University Hospital, Egypt
- Last refreshed: 23 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05734287.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing